|
Novaleads addresses screening needs for GPCR and RTK therapeutic targets with four functional assays that exploit cell signalling pathway protein translocation events.
|
| * since the cAMP pathway does not involve protein translocation, a modified PKA able to translocate between the cytopasm and plasma membrane has been constructed (W0 03/085405) |
agonists ?
